T1	Participants 279 371	patients with heart failure who were in sinus rhythm and whose ejection fraction was </=0.45
T2	Participants 427 534	large number of centers (302) in the United States and Canada, many of which were inexperienced in research
T3	Participants 1249 1404	Of the total 7788 participants entered into the DIG trial, only 97 participants (1.2%) could not have their vital status as of December 31, 1995 determined
